4-125318831-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001291303.3(FAT4):​c.2420C>T​(p.Ala807Val) variant causes a missense change. The variant allele was found at a frequency of 0.438 in 1,613,752 control chromosomes in the GnomAD database, including 157,577 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. A807A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.46 ( 16453 hom., cov: 32)
Exomes 𝑓: 0.44 ( 141124 hom. )

Consequence

FAT4
NM_001291303.3 missense

Scores

6
12

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 3.68

Publications

43 publications found
Variant links:
Genes affected
FAT4 (HGNC:23109): (FAT atypical cadherin 4) The protein encoded by this gene is a member of the protocadherin family. This gene may play a role in regulating planar cell polarity (PCP). Studies in mice suggest that loss of PCP signaling may cause cystic kidney disease, and mutations in this gene have been associated with Van Maldergem Syndrome 2. Alternatively spliced transcript variants have been noted for this gene. [provided by RefSeq, Mar 2014]
FAT4 Gene-Disease associations (from GenCC):
  • Hennekam lymphangiectasia-lymphedema syndrome 2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • van Maldergem syndrome 2
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • multiple congenital anomalies/dysmorphic syndrome-intellectual disability
    Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics
  • Hennekam syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • van Maldergem syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=2.4184585E-4).
BP6
Variant 4-125318831-C-T is Benign according to our data. Variant chr4-125318831-C-T is described in ClinVar as Benign. ClinVar VariationId is 380329.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.561 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FAT4NM_001291303.3 linkc.2420C>T p.Ala807Val missense_variant Exon 2 of 18 ENST00000394329.9 NP_001278232.1 Q6V0I7A0A6Q8JR05X2G5I7B3KU84

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FAT4ENST00000394329.9 linkc.2420C>T p.Ala807Val missense_variant Exon 2 of 18 5 NM_001291303.3 ENSP00000377862.4 A0A6Q8JR05
FAT4ENST00000678072.1 linkn.26C>T non_coding_transcript_exon_variant Exon 1 of 2
FAT4ENST00000674496.2 linkc.-55+2854C>T intron_variant Intron 1 of 16 ENSP00000501473.2 A0A7P0T1I0

Frequencies

GnomAD3 genomes
AF:
0.459
AC:
69743
AN:
151826
Hom.:
16427
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.566
Gnomad AMI
AF:
0.471
Gnomad AMR
AF:
0.403
Gnomad ASJ
AF:
0.352
Gnomad EAS
AF:
0.244
Gnomad SAS
AF:
0.386
Gnomad FIN
AF:
0.393
Gnomad MID
AF:
0.322
Gnomad NFE
AF:
0.445
Gnomad OTH
AF:
0.439
GnomAD2 exomes
AF:
0.413
AC:
103088
AN:
249352
AF XY:
0.412
show subpopulations
Gnomad AFR exome
AF:
0.573
Gnomad AMR exome
AF:
0.377
Gnomad ASJ exome
AF:
0.365
Gnomad EAS exome
AF:
0.230
Gnomad FIN exome
AF:
0.384
Gnomad NFE exome
AF:
0.443
Gnomad OTH exome
AF:
0.411
GnomAD4 exome
AF:
0.436
AC:
636920
AN:
1461808
Hom.:
141124
Cov.:
69
AF XY:
0.434
AC XY:
315491
AN XY:
727216
show subpopulations
African (AFR)
AF:
0.576
AC:
19291
AN:
33480
American (AMR)
AF:
0.381
AC:
17027
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.364
AC:
9507
AN:
26134
East Asian (EAS)
AF:
0.236
AC:
9379
AN:
39700
South Asian (SAS)
AF:
0.406
AC:
35028
AN:
86254
European-Finnish (FIN)
AF:
0.390
AC:
20842
AN:
53394
Middle Eastern (MID)
AF:
0.354
AC:
2043
AN:
5768
European-Non Finnish (NFE)
AF:
0.448
AC:
498518
AN:
1111968
Other (OTH)
AF:
0.419
AC:
25285
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
23552
47103
70655
94206
117758
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
15012
30024
45036
60048
75060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.460
AC:
69823
AN:
151944
Hom.:
16453
Cov.:
32
AF XY:
0.454
AC XY:
33725
AN XY:
74268
show subpopulations
African (AFR)
AF:
0.567
AC:
23475
AN:
41412
American (AMR)
AF:
0.403
AC:
6149
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.352
AC:
1223
AN:
3472
East Asian (EAS)
AF:
0.244
AC:
1256
AN:
5152
South Asian (SAS)
AF:
0.387
AC:
1862
AN:
4814
European-Finnish (FIN)
AF:
0.393
AC:
4147
AN:
10558
Middle Eastern (MID)
AF:
0.336
AC:
98
AN:
292
European-Non Finnish (NFE)
AF:
0.445
AC:
30268
AN:
67950
Other (OTH)
AF:
0.434
AC:
918
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1922
3844
5766
7688
9610
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
626
1252
1878
2504
3130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.442
Hom.:
72226
Bravo
AF:
0.463
TwinsUK
AF:
0.463
AC:
1715
ALSPAC
AF:
0.441
AC:
1700
ESP6500AA
AF:
0.542
AC:
2195
ESP6500EA
AF:
0.426
AC:
3568
ExAC
AF:
0.422
AC:
51004
Asia WGS
AF:
0.341
AC:
1189
AN:
3478
EpiCase
AF:
0.432
EpiControl
AF:
0.427

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 11, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: 42% of total chromosomes in ExAC -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 66% of patients studied by a panel of primary immunodeficiencies. Number of patients: 63. Only high quality variants are reported. -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Van Maldergem syndrome 2 Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hennekam lymphangiectasia-lymphedema syndrome 2 Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.72
T
BayesDel_noAF
Benign
-0.66
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Benign
0.13
T
Eigen
Benign
0.15
Eigen_PC
Uncertain
0.23
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Uncertain
0.93
D
MetaRNN
Benign
0.00024
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.84
L
PhyloP100
3.7
PrimateAI
Uncertain
0.66
T
PROVEAN
Benign
-1.6
N
REVEL
Benign
0.12
Sift
Benign
0.20
T
Sift4G
Uncertain
0.016
D
Polyphen
0.57
P
Vest4
0.13
MPC
0.50
ClinPred
0.020
T
GERP RS
5.1
Varity_R
0.26
gMVP
0.26
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1039808; hg19: chr4-126239986; COSMIC: COSV67882879; API